Close this search box.
Close this search box.

Paragard Settlement Talks to Be Overseen by Court-Appointed Mediator

By Nairis Pimentel

Paragard, a type of intrauterine device (IUD) manufactured by Teva Pharmaceuticals, has been the subject of numerous lawsuits in recent years. These lawsuits have claimed that the device (meant to provide long-term contraception) can break or fracture upon removal, leading to:

  • Injuries
  • Infection
  • Other complications here

Court-Appointed Mediator [1]

In response to these lawsuits, Teva has entered settlement talks with plaintiffs. For which it was announced that these talks will be overseen by M. Gino Brogdon, Sr., a court-appointed mediator. Meaning that the negotiations between Teva and the plaintiffs will be conducted under the supervision of a neutral third party, who will help to facilitate a resolution that is fair and acceptable to both sides.

The first conference to involve Mr. Brogdon will occur on January 30, 2023. If a settlement is not reached, a series of bellwether trials are scheduled to start in March 2024. The use of a mediator in this process can be beneficial, as it can help to reduce the tension and animosity that can sometimes arise in negotiations and lead to a quicker and more amicable resolution.

The appointment of a mediator is a positive step towards resolving the lawsuits against Paragard IUD. The use of a neutral third party can help to ensure that the negotiations are conducted in a fair and transparent manner and that the rights of both Teva and the plaintiffs are protected.

As the litigation advances, if you have any questions or concerns regarding your existing or potential Paragard case; please contact us for a free consultation at 212-684-1880.

[1] Jackson, I. (2023, January 23). Paragard IUD Settlement Talks To Be Overseen By Court-Appointed Mediator.

Related Posts

Port-a-Cath Injuries

By Mia Wang What is a Port-a-Cath? A port-a-cath is used to give fluids, blood transfusions, chemotherapy, antibiotics, food, and other drugs through the blood

View Article